1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Luitpold Pharmaceuticals

Anonymous board for Luitpold Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    4
    Views:
    5,929
  2. anonymous
    Replies:
    3
    Views:
    4,894
  3. pecan204
    Replies:
    1
    Views:
    1,403
  4. anonymous
    Replies:
    1
    Views:
    1,852
  5. anonymous
    Replies:
    3
    Views:
    2,537
  6. anonymous
    Replies:
    0
    Views:
    3,239
  7. Anonymous
    Replies:
    18
    Views:
    9,055
  8. anonymous
    Replies:
    4
    Views:
    3,408
  9. anonymous
    Replies:
    0
    Views:
    2,762
  10. anonymous
    Replies:
    1
    Views:
    2,762
  11. Anonymous
    Replies:
    19
    Views:
    7,210
  12. anonymous
    Replies:
    2
    Views:
    2,745
  13. anonymous
    Replies:
    2
    Views:
    2,562
  14. anonymous
    Replies:
    9
    Views:
    2,554
  15. anonymous
    Replies:
    6
    Views:
    3,938
  16. Anonymous
    Replies:
    2
    Views:
    3,612
  17. Anonymous
    Replies:
    42
    Views:
    20,546
  18. Anonymous
    Replies:
    6
    Views:
    5,053
  19. Anonymous
    Replies:
    4
    Views:
    3,816
  20. Anonymous
    Replies:
    3
    Views:
    4,004

Thread Display Options

Loading...